Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...

Hyderabad: Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III clinical trials. The vaccine maker, in a press release, said it has ...

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b ...

Pursuant to Regulation 30 and 33 of SEBI (LODR) regulations, 2015, as amended from time to time. We enclosed herewith Unaudited Standalone and Consolidated Financial results of the company for the ...

Genomic Valley Biotech, operating in the Bio Technology sector and classified as a Smallcap on the BSE, currently has its share price at ₹60.27. The stock has experienced fluctuations today ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

E-commerce giant Meesho’s board has approved the renaming of its Indian entity from Fashnear Technologies to Meesho Pvt Ltd, according to regulatory filings accessed via Toflr. The company has ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We wish to inform you that the Company has received US FDA approval for the sterile injectable Oncology Formulation facility at Haridwar.

The antibody is in preclinical development and is expected to enter the clinic next year. The biotech hopes to bring first-in-class therapies to patients impacted by inflammation, autoimmunity and ...